4111.TWO
Price:
$31.5
Market Cap:
$1.79B
Chi Sheng Pharma & Biotech Co., Ltd engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally. Its products portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerves agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and anti-asthmas; gastro-intestinal preparations; local anesthetic preparations; hemodialysis concentrate and external solutions; per...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
4111.TWO
According to Chi Sheng Pharma & Biotech Co., Ltd’s latest financial reports and current stock price. The company's current ROE is 10.06%. This represents a change of 303.61% compared to the average of 2.49% of the last 4 quarters.
The mean historical ROE of Chi Sheng Pharma & Biotech Co., Ltd over the last ten years is 7.75%. The current 10.06% ROE has changed 29.80% with respect to the historical average. Over the past ten years (40 quarters), 4111.TWO's ROE was at its highest in in the December 2022 quarter at 4.45%. The ROE was at its lowest in in the December 2023 quarter at 0.62%.
Average
7.75%
Median
7.05%
Minimum
5.50%
Maximum
12.60%
Discovering the peaks and valleys of Chi Sheng Pharma & Biotech Co., Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 71.77%
Maximum Annual ROE = 12.60%
Minimum Annual Increase = -55.30%
Minimum Annual ROE = 5.50%
Year | ROE | Change |
---|---|---|
2024 | 8.68% | 54.09% |
2023 | 5.63% | -55.30% |
2022 | 12.60% | 71.77% |
2021 | 7.34% | 33.44% |
2020 | 5.50% | -18.67% |
The current ROE of Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.97%
5-year avg
7.95%
10-year avg
7.75%
Chi Sheng Pharma & Biotech Co., Ltd’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chi Sheng Pharma & Biotech Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chi Sheng Pharma & Biotech Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Chi Sheng Pharma & Biotech Co., Ltd's ROE?
How is the ROE calculated for Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)?
What is the highest ROE for Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)?
What is the 3-year average ROE for Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)?
What is the 5-year average ROE for Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)?
How does the current ROE for Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) compare to its historical average?